These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

129 related articles for article (PubMed ID: 20955381)

  • 1. HER2 molecular subtype is a dominant subtype of mammary Paget's cells. An immunohistochemical study.
    Sek P; Zawrocki A; Biernat W; Piekarski JH
    Histopathology; 2010 Oct; 57(4):564-71. PubMed ID: 20955381
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Molecular subtyping of mammary Paget's disease using immunohistochemistry.
    Arafah M; Arain SA; Raddaoui EMS; Tulba A; Alkhawaja FH; Al Shedoukhy A
    Saudi Med J; 2019 May; 40(5):440-446. PubMed ID: 31056619
    [TBL] [Abstract][Full Text] [Related]  

  • 3. [Comparative immunohistochemical study of invasive duct carcinoma and Paget's disease of the breast with c-erbB-2 overexpression].
    Petrov SV; Raskin GA; Khasanov RSh; Tsyplakov DE
    Arkh Patol; 2006; 68(5):10-4. PubMed ID: 17144522
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Study of neu-protein expression in mammary Paget's disease with and without underlying breast carcinoma and in extramammary Paget's disease.
    Meissner K; Rivière A; Haupt G; Löning T
    Am J Pathol; 1990 Dec; 137(6):1305-9. PubMed ID: 1701961
    [TBL] [Abstract][Full Text] [Related]  

  • 5. [Expression status of HER2 in mammary and extramammary Paget's disease].
    Meng H; Zheng XY; Zhang L; Li WC
    Zhonghua Bing Li Xue Za Zhi; 2011 Apr; 40(4):255-6. PubMed ID: 21616001
    [No Abstract]   [Full Text] [Related]  

  • 6. [Expression of the c-erbB-2 oncoprotein in mammary Paget's disease. Immunohistochemical study by using 3 antibodies].
    Edorh A; Parache RM; Migeon C; N'Sossani B; Rihn B
    Pathol Biol (Paris); 1995 Sep; 43(7):584-9. PubMed ID: 8570262
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Paget's disease of the nipple: a copy number of the genes ERBB2 and CCND1 versus expression of the proteins ERBB-2 and cyclin D1.
    Mrhalova M; Kodet R
    Neoplasma; 2003; 50(6):396-402. PubMed ID: 14689059
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Androgen receptors are frequently expressed in mammary and extramammary Paget's disease.
    Liegl B; Horn LC; Moinfar F
    Mod Pathol; 2005 Oct; 18(10):1283-8. PubMed ID: 15920545
    [TBL] [Abstract][Full Text] [Related]  

  • 9. c-erbB-2 oncoprotein expression in mammary and extramammary Paget's disease: an immunohistochemical study.
    Keatings L; Sinclair J; Wright C; Corbett IP; Watchorn C; Hennessy C; Angus B; Lennard T; Horne CH
    Histopathology; 1990 Sep; 17(3):243-7. PubMed ID: 2173676
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Different panels of markers should be used to predict mammary Paget's disease associated with in situ or invasive ductal carcinoma of the breast.
    Lester T; Wang J; Bourne P; Yang Q; Fu L; Tang P
    Ann Clin Lab Sci; 2009; 39(1):17-24. PubMed ID: 19201736
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Paget's disease in contralateral breast occuring 11 years after mastectomy for invasive ductal carcinoma.
    Salopek D; Murgić J; Tomas D; Bolanca A; Kusić Z
    Coll Antropol; 2009 Mar; 33(1):327-9. PubMed ID: 19408647
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Mammary and extramammary Paget's disease: an immunohistochemical study of 83 cases.
    Liegl B; Leibl S; Gogg-Kamerer M; Tessaro B; Horn LC; Moinfar F
    Histopathology; 2007 Mar; 50(4):439-47. PubMed ID: 17448019
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Mammary Paget's disease and associated carcinoma. An immunohistochemical study.
    Cohen C; Guarner J; DeRose PB
    Arch Pathol Lab Med; 1993 Mar; 117(3):291-4. PubMed ID: 7680194
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Immunohistochemical identification of basal-type cytokeratins in invasive ductal breast carcinoma--relation with grade, stage, estrogen receptor and HER2.
    Kusińska R; Potemski P; Jesionek-Kupnicka D; Kordek R
    Pol J Pathol; 2005; 56(3):107-10. PubMed ID: 16334976
    [TBL] [Abstract][Full Text] [Related]  

  • 15. COX-2 and Her-2/neu are overexpressed in Paget's disease of the vulva and the breast: results of a preliminary study.
    Horn LC; Purz S; Krumpe C; Bilek K
    Arch Gynecol Obstet; 2008 Feb; 277(2):135-8. PubMed ID: 17701193
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Glandular Paget's disease of the nipple.
    Shousha S
    Histopathology; 2007 May; 50(6):812-4. PubMed ID: 17376174
    [No Abstract]   [Full Text] [Related]  

  • 17. Minimally invasive mammary Paget's disease without an underlying breast carcinoma.
    Hanna M; Jaffer S; Bleiweiss IJ; Nayak A
    Virchows Arch; 2013 Sep; 463(3):471-3. PubMed ID: 23851623
    [No Abstract]   [Full Text] [Related]  

  • 18. HER2 oncogene amplification in extramammary Paget's disease.
    Tanskanen M; Jahkola T; Asko-Seljavaara S; Jalkanen J; Isola J
    Histopathology; 2003 Jun; 42(6):575-9. PubMed ID: 12786893
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Toker-cell pathology as a unifying concept.
    Fernandez-Flores A
    Histopathology; 2008 Jun; 52(7):889-91; author reply 891-2. PubMed ID: 18462365
    [No Abstract]   [Full Text] [Related]  

  • 20. Toker cells of the breast. Morphological and immunohistochemical characterization of 40 cases.
    Di Tommaso L; Franchi G; Destro A; Broglia F; Minuti F; Rahal D; Roncalli M
    Hum Pathol; 2008 Sep; 39(9):1295-300. PubMed ID: 18614197
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.